Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease

NCT00004409 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Dupuytren's Contracture

Interventions

DRUG: collagenase

Sponsor

State University of New York